Αρχική World News Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma World News Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma Από Ogkologos - 10 Φεβρουαρίου, 2025 895 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR England slips further off-track for smokefree 2030 target 29 Δεκεμβρίου, 2022 Giving Myself the Most Time and Best Chance at Beating Cancer:... 10 Οκτωβρίου, 2023 Immunotherapy after Surgery Shows Long-Term Benefits for High-Risk Bladder Cancer 21 Μαρτίου, 2023 Learning the lessons of COVID-19: Protecting cancer services and research through... 9 Νοεμβρίου, 2020 Φόρτωση περισσοτέρων HOT NEWS Όροι χρήσης και προϋποθέσεις Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated... Understanding Serving Sizes Pembrolizumab Does Not Prolong Overall Survival Compared to Chemotherapy in Platinum-Pretreated...